Author

Ibrahim Mohammed Hepishy

View on Semantic Scholar

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration.

It is established that allosteric EGFR inhibition represents a clinically viable strategy for addressing osimertinib resistance, with lead candidates ready for clinical translation.

Ibrahim Mohammed Hepishy, Mo'men Salem, A. El-Morsy et al. · Bioorganic chemistry (Print) · 0 citations